Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-(4-nitrobenzyl)glutathione is a synthetic S-substituted glutathione derivative in which the thiol hydrogen of glutathione is replaced by a 4-nitrobenzyl group. It belongs to the class of oligopeptides and organic sulfides. This compound is primarily used as an experimental tool in biochemical research, notably as a competitive inhibitor of glutathionase (gamma-glutamyl transpeptidase). It serves as a model substrate or ligand for studying glutathione transferases (GSTs), including their structure, function, and ligand-binding properties[1][2][5][7]. There are no approved therapeutic indications or clinical uses for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on s-(4-nitrobenzyl)glutathione.